A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceuticals company,
announced today it has made a stock option grant to Ronald J. Prentki,
who joined the company on...
A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical
company, has appointed Ronald J. Prentki as President, Chief Executive
Officer and a member of the company’s...
A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceuticals company,
today announced that its board of directors has initiated an executive
succession program designed to recruit...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today reported financial results for its fourth quarter and full year ended...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, will release its 2006 fourth quarter and year end financial results before...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage of AP Pharma (Nasdaq:APPA) with
an upgrade of its rating to Strong Speculative Buy. The 10-page report ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical
company, reported today that it believes that it will not meet a
previously...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical
company, today announced that Anastassios D. Retzios, Ph.D. has joined
the Company...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical
company, today reported financial results for the three months ended
September 30,...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical
company, will release its 2006 third quarter financial results before
the market...
REDWOOD CITY, Calif. & NEW HAVEN, Conn.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA) and RHEI Pharmaceuticals, Inc.
today announced that A.P. Pharma has granted an exclusive license to...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical
company, today announced that it expects to have initial data from its
Phase 3...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Sept. 12, 2006--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced it will present at the Merriman Curhan Ford "Investor...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 14, 2006--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced that Arthur T. Taylor has joined the Company's board of...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 8, 2006--A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today reported financial results for the three months ended June 30, 2006....